A study found that the triglyceride-glucose (TyG) index, combined with obesity measures, significantly correlates with hypertension risk in American adults, offering potential for improved cardiovascular risk assessment.
Bluejay touts positive data for chronic hepatitis D treatment – Pharmaceutical Technology
BJT-778 is a monoclonal antibody that acts against hepatitis B surface antigen (anti-HBsAg mAb). Credits: Jo Panuwat D / Shutterstock. Bluejay Therapeutics has released positive